BlackRock
LHDX

BlackRock’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

BlackRock’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-53,206
Closed -$5.91K – 5790
2022
Q4 		$5.91K Buy
53,206
+920
+2% +$587 ﹤0.01% 5509
2022
Q3 		$56K Sell
52,286
-1,150
-2% -$2.62K ﹤0.01% 5334
2022
Q2 		$99K Buy
53,436
+1,968
+4% +$4.78K ﹤0.01% 5242
2022
Q1 		$183K Buy
51,468
+8,131
+19% +$39.9K ﹤0.01% 5125
2021
Q4 		$373K Sell
43,337
-10,824
-20% -$68.8K ﹤0.01% 4960
2021
Q3 		$412K Buy
54,161
+25,913
+92% +$219K ﹤0.01% 4814
2021
Q2 		$187K Sell
28,248
-441,267
-94% -$2.78M ﹤0.01% 4905
2021
Q1 		$5.68M Buy
+469,515
New +$9.31M ﹤0.01% 3885

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return